ASLAN’s A4 webinar series: ‘Dialogues with International Thought Leaders in Dermatology’ featured a series of Key Opinion Leader (KOL) events on the emerging Atopic Dermatitis (AD) landscape and ASLAN004 (eblasakimab)
Jonathan Silverberg, MD PhD MPH
Heterogeneity in AD
Associate Professor of Dermatology
George Washington University School of Medicine and Health Sciences
Accompanying slides, A4 KOL Series: Episode 1, Jonathan Silverberg
April Armstrong, MD MPH
A closer look: Key factors impacting responses in AD clinical trials
Professor of Dermatology and Associate Dean
University of Southern California
Accompanying slides, A4 KOL Series: Episode 2, April Armstrong
Peter Lio, MD
AD: Patient journeys and unmet needs
Clinical Assistant Professor of Dermatology and Pediatrics,
Northwestern University Fienberg School of Medicine